Corvus Pharmaceuticals
CRVS
CRVS
52 hedge funds and large institutions have $28M invested in Corvus Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 10 closing their positions.
Holders
52
Holders Change
–
Holders Change %
0%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
15
Reduced
11
Closed
10
Calls
$114K
Puts
$113K
Net Calls
+$1K
Net Calls Change
+$7K
Top Buyers
| 1 |
SC
1
Samlyn Capital
New York
|
$3.51M |
| 2 |
TL
2
TowerView LLC
New York
|
$500K |
| 3 |
3
Millennium Management
New York
|
$158K |
| 4 |
4
Two Sigma Advisers
New York
|
$363K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$102K |
